ScholarIQanswers from OpenAlex
Ampel BioSolutions (United States)
InstitutionResearch output, impact & collaborations
Ampel BioSolutions (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Ampel BioSolutions (United States)?
ScholarIQrecord summary
Ampel BioSolutions (United States) is a research organisation in Charlottesville, US. OpenAlex records 261 works and 13,192 citations for it.
How many works does Ampel BioSolutions (United States) have?
ScholarIQindexed works
Ampel BioSolutions (United States) has 261 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ampel BioSolutions (United States) have?
ScholarIQcitation count
Ampel BioSolutions (United States) has 13,192 citations in the OpenAlex counts ScholarIQ stores.
What is the average h-index at Ampel BioSolutions (United States)?
ScholarIQavg h-index
Ampel BioSolutions (United States) has an average h-index of 44.7 in OpenAlex.
What is the ROR of Ampel BioSolutions (United States)?
ScholarIQror
The ROR for Ampel BioSolutions (United States) is on the source record.
What is the OpenAlex record for Ampel BioSolutions (United States)?
ScholarIQopenalex
The OpenAlex for Ampel BioSolutions (United States) is on the source record.
Who are the most-cited researchers behind Ampel BioSolutions (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Ampel BioSolutions (United States)?
ScholarIQmost cited works
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
Cyclooxygenase in biology and disease
Raymond N. DuBois, Steven B. Abramson, Leslie J. Crofford, Rajnish A. Gupta, Lee S. Simon, L. B. A. van de Putte, Peter E. Lipsky
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky
Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease
Sandro Dá Mesquita, Antoine Louveau, Andrea Vaccari, Igor Smirnov, R. Chase Cornelison, Kathryn M. Kingsmore, Christian Contarino, Suna Önengüt-Gümüşcü, Emily Farber, Daniel Raper, Kenneth E. Viar, Romie D. Powell, Wendy Baker, Nisha Dabhi, Robin Bai, Rui Cao, Song Hu, Stephen S. Rich, Jennifer M. Munson, M. Beatriz S. Lopes, Christopher C. Overall, Scott T. Acton, Jonathan Kipnis
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Sheng Chen, Sheng Chen, Gary P. Sims, Xiao Xiang Chen, Yue Ying Gu, Shunle Chen, Shun‐le Chen, Peter E. Lipsky
How much of the research on Ampel BioSolutions (United States) is open access?
ScholarIQopen access share
50%OPEN ACCESS